Skip to main content
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mSphere
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Research Article | Therapeutics and Prevention

Repurposing Pilocarpine Hydrochloride for Treatment of Candida albicans Infections

Christopher Nile, Monica Falleni, Daniela Cirasola, Abeer Alghamdi, Oliver F. Anderson, Christopher Delaney, Gordon Ramage, Emerenziana Ottaviano, Delfina Tosi, Gaetano Bulfamante, Giulia Morace, Elisa Borghi
J. Andrew Alspaugh, Editor
Christopher Nile
aOral Sciences Research Group, University of Glasgow Dental School, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monica Falleni
bDivision of Human Pathology, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniela Cirasola
cLaboratory of Microbiology, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abeer Alghamdi
aOral Sciences Research Group, University of Glasgow Dental School, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver F. Anderson
aOral Sciences Research Group, University of Glasgow Dental School, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Delaney
aOral Sciences Research Group, University of Glasgow Dental School, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gordon Ramage
aOral Sciences Research Group, University of Glasgow Dental School, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emerenziana Ottaviano
cLaboratory of Microbiology, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Delfina Tosi
bDivision of Human Pathology, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gaetano Bulfamante
bDivision of Human Pathology, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giulia Morace
cLaboratory of Microbiology, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisa Borghi
cLaboratory of Microbiology, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Andrew Alspaugh
Duke University Medical Center
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mSphere.00689-18
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    The general muscarinic receptor agonist pilocarpine hydrochloride inhibits Candida albicans biofilm formation in vitro. (A and B) Biofilm biomass was assessed using the crystal violet assay after C. albicans was cultured for 24 h in RPMI 1640 containing different concentrations of SIBm (0 to 10 mM) (A) and PHCl (0 to 50 mM) (B). Data are expressed as raw OD595 values, and the bars represent the mean values (plus standard deviations [SD] [error bars]) from triplicate wells of six independent experiments (n = 6). (C and D) Biofilm metabolic activity was assessed using the XTT assay after C. albicans was cultured for 24 h in RPMI 1640 containing different concentrations of SIBm (0 to 10 mM) (C) and PHCl (0 to 50 mM) (D). Data are expressed as percent metabolic activity compared to untreated controls (0 mM PHCl), and the bars represent the mean values (+SD) from triplicate wells of six independent experiments (n = 6). For panels A to D, values that are significantly different compared to the control values (0 mM SIBm or PHCl) are indicated by asterisks as follows: *, P < 0.05; **, P < 0.01; ***, P < 0.001. (E and F) The effect of PHCl on the permeability of the C. albicans cell wall was investigated using a propidium iodide (PI) uptake (E) and ATP release assay (F). For the PI uptake assay, data are shown as fluorescence intensity units, and the bars represent the mean values (+SD) from triplicate wells of three independent experiments (n = 3). Heat-killed (HK) and chlorhexidine (CHX) (0.2%)-treated C. albicans were included as positive controls, and cells in RPMI 1640 alone were included as a negative control. For the ATP release assays, data are shown as nanomolar concentrations of ATP release, and the bars represent the mean values (+SD) from triplicate wells of three independent experiments (n = 3). Chlorhexidine (0.2%)- and fulvic acid (2.0%)-treated C. albicans cells were included as positive controls, and cells in RPMI 1640 alone were included as a negative control. *, P < 0.05; **, P < 0.01 compared to the control (cells in RPMI 1640 alone).

  • FIG 2
    • Open in new tab
    • Download powerpoint
    FIG 2

    The general muscarinic receptor agonist pilocarpine hydrochloride inhibits filamentation and biofilm formation in vitro without affecting cell viability. (A to J) To assess the effects of PHCl on C. albicans morphology and viability, microscopy was employed. Light microscopy (LM) (A to E) and scanning electron microscopy (SEM) (F to J) was performed to visualize changes in biofilm biomass and C. albicans cell morphology after culture for 24 h in RPMI 1640 containing different concentrations of PHCl (0 to 50 mM). Representative images are shown from duplicate coverslips of three independent experiments. YC, yeast cells; PH, pseudohyphae; TH, true hyphae. Bars, 100 µm (A to E) and 700 µm (F to J). (K to O) Fluorescence microscopy (FM) was performed to assess cell viability. C. albicans was cultured for 24 h in RPMI 1640 containing different concentrations of PHCl, and viability was assessed using calcofluor white (blue) and propidium iodide (red) staining. Representative images are shown from duplicate coverslips of three independent experiments. Bars, 100 µm.

  • FIG 3
    • Open in new tab
    • Download powerpoint
    FIG 3

    Pilocarpine hydrochloride acts through a specific muscarinic-like receptor to inhibit biofilm formation and modulate cell wall hydrophobicity. (A) Biofilm biomass was assessed using the crystal violet assay after C. albicans was cultured for 24 h in RPMI 1640 containing 25 mM PHCl and different concentrations of the nonspecific muscarinic receptor antagonist scopolamine (SCP) (0 to 128 µM). Data are expressed as raw OD595 values, and the bars represent the mean values (+SD) from triplicate wells of three independent experiments (n = 3). Candida albicans was cultured in the absence of any compound, in the presence of PHCl alone, and in the presence of SCP alone as controls. #, significantly different from cells cultured in the absence of any compound; *, significantly different from cells cultured in PHCl alone; * or #, P < 0.05; ** or ##, = P < 0.01; *** or ###, P < 0.001. (B) Biofilm metabolic activity was assessed using the XTT assay after C. albicans was cultured for 24 h in RPMI 1640 containing 25 mM PHCl and different concentrations of the nonspecific muscarinic receptor antagonist scopolamine (SCP) (0 to 128 µM). Data are expressed as percent metabolic activity compared to untreated controls (0 mM PHCl or SCP), and the bars represent the mean values (+SD) from triplicate wells of three independent experiments (n = 3). Candida albicans cultured in the presence of PHCl and SCP alone acted as controls. *, significantly different from cells cultured in SCP alone; ***, P < 0.001. (C) Cell wall hydrophobicity was assessed using the MATH assay (29). The bars represent the mean values (+SD) from duplicate samples of five independent experiments (n = 5). #, significantly different from cells cultured planktonically; *, significantly different from cells cultured as a biofilm in the absence of PHCl.

  • FIG 4
    • Open in new tab
    • Download powerpoint
    FIG 4

    Pilocarpine hydrochloride acts through muscarinic-like receptors to prolong survival of Candida albicans-infected Galleria mellonella by inhibiting biofilm formation and modulating host immunity in vivo. The effect of PHCl on the outcome of systemic candidiasis was investigated using a G. mellonella infection model. (A) A Kaplan-Meier plot shows the effects of different concentrations of PHCl on the survival of Candida albicans-infected larvae. The data are derived from three independent experiments with groups of 16 larvae (n = 48). ***, P < 0.001; *, P < 0.05, as determined by the log rank test in comparison to larvae inoculated with C. albicans alone. PBS alone and PHCl alone-injected larvae were used as controls and had no effect on larvae survival. (B) To verify specificity, C. albicans-infected larvae were also inoculated with PHCl and SCP in combination. The data are derived from three independent experiments with groups of 16 larvae (n = 48). *, P < 0.05, as determined by the log rank test in comparison to larvae inoculated with C. albicans. Larvae injected with PBS alone and SCP alone were used as controls, and PBS and SCP alone had no effect on larva survival. (C) Histological analysis of larvae was performed at 24 and 48 h postinoculation using hematoxylin and eosin (HE) and periodic acid-Schiff (PAS) staining. (i and vi; HE) (ii and vii; HE) larva inoculated with PHCl (6.25 mM) alone. (iii and viii; PAS) larvae infected with C. albicans. (iv and ix; HE) larvae infected with C. albicans in the presence of PHCl (6.25 mM). (v and x; PAS). Larvae infected with C. albicans in the presence of PHCl (6.25 mM) and SCP (6.25 mM). Asterisks highlight melanized nodules, whereas arrows show C. albicans cells and hyphae. Representative images are shown from histological analysis of two larvae for each condition from three independent experiments. Fb, fat body; Ct, cuticle; GI, gastrointestinal tract; T, trachea; Nd, nodule. Bars, 250 μm (panels i, v, and ix) and 100 μm (panels ii, iii, iv, vi, vii, viii, and x).

  • FIG 5
    • Open in new tab
    • Download powerpoint
    FIG 5

    Effects of pilocarpine hydrochloride and acetylcholine on hemocyte responses to C. albicans in vitro and in vivo. (A) In the in vitro study, hemocytes isolated from untreated larvae were either left unstimulated (control) (i) or stimulated with C. albicans (ii), ACh (iii), PHCl (iv), C. albicans plus ACh (v), and C. albicans plus PHCl for 24 h. (B) In the in vivo study, larvae were bled 24 h after sham inoculation with PBS (control) (i) or inoculation with C. albicans (ii), ACh (iii), PHCl (iv), C. albicans plus ACh (v), and C. albicans plus PHCl. Representative images are shown from hematoxylin and eosin staining of hemocytes from three larvae for each condition from three independent experiments. Bars, 100 μm.

Tables

  • Figures
  • TABLE 1

    Effects of pilocarpine hydrochloride and acetylcholine on hemocyte cellularity and subtype characteristics in vitro and in vivo

    Condition
    and treatmenta
    CellularityHemocyte subsetbNoduleC. albicansc
    PrGrPlCoSpAdOeSizeMelanization
    In vitro
        CTRLow++−−++−−−−
        SC5314High+++++++++++Medium+++++
        AChHigh+++++++−−−Medium−−
        PHClLow++−−++−−−−
        SC5314/AChHigh+++++++++++−Large−+
        SC5314/PHClHigh++++++++++Small−+
    In vivo
        CTRLow++−−++−−−−
        SC5314High++++++++++++Large++++++
        AChIntermediate+++++++−−−Medium−−
        PHClLow+++−++−−−−
        SC5314/AChIntermediate++++++++++++Large−+
        SC5314/PHClIntermediate+++++++++++Small−+
    • ↵a Galleria mellonella larvae were inoculated with PBS (control [CTR]), C. albicans SC5314, acetylcholine (ACh), pilocarpine hydrochloride (PHCl), C. albicans plus ACh (SC3514/ACh), and C. albicans plus PHCl (SC5314/PHCl).

    • ↵b Pr, prohemocytes; Gr, granulocytes; Pl, plasmatocytes; Co, coagulocytes; Sp, spherulocytes; Ad, adipocytes; Oe, oenocytes. Immune cell subtype quantification was scored as follows: −, absent/rare; +, 1 to 10%; ++, 11 to 30%; +++, 31 to 50%.

    • ↵c C. albicans presence was quantified as follows: −, absent; +, few cells; ++, multiple yeast agglomerate usually embedded in nodules; +++, abundant yeasts and/or hyphae with widespread diffusion in nodules.

PreviousNext
Back to top
Download PDF
Citation Tools
Repurposing Pilocarpine Hydrochloride for Treatment of Candida albicans Infections
Christopher Nile, Monica Falleni, Daniela Cirasola, Abeer Alghamdi, Oliver F. Anderson, Christopher Delaney, Gordon Ramage, Emerenziana Ottaviano, Delfina Tosi, Gaetano Bulfamante, Giulia Morace, Elisa Borghi
mSphere Jan 2019, 4 (1) e00689-18; DOI: 10.1128/mSphere.00689-18

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print
Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mSphere article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Repurposing Pilocarpine Hydrochloride for Treatment of Candida albicans Infections
(Your Name) has forwarded a page to you from mSphere
(Your Name) thought you would be interested in this article in mSphere.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Repurposing Pilocarpine Hydrochloride for Treatment of Candida albicans Infections
Christopher Nile, Monica Falleni, Daniela Cirasola, Abeer Alghamdi, Oliver F. Anderson, Christopher Delaney, Gordon Ramage, Emerenziana Ottaviano, Delfina Tosi, Gaetano Bulfamante, Giulia Morace, Elisa Borghi
mSphere Jan 2019, 4 (1) e00689-18; DOI: 10.1128/mSphere.00689-18
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Candida albicans
Galleria mellonella
biofilm
muscarinic
pilocarpine hydrochloride
repurposing

Related Articles

Cited By...

About

  • About mSphere
  • Board of Editors
  • Policies
  • For Reviewers
  • For the Media
  • Embargo Policy
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Types of Articles
  • Getting Started
  • Ethics
  • Contact Us

Follow #mSphereJ

@ASMicrobiology

       

 

Website feedback

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2379-5042